94 related articles for article (PubMed ID: 11313929)
21. Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB.
Lee ZH; Kwack K; Kim KK; Lee SH; Kim HH
Mol Pharmacol; 2000 Dec; 58(6):1536-45. PubMed ID: 11093794
[TBL] [Abstract][Full Text] [Related]
22. A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts.
Mazzieri R; Furlan F; D'Alessio S; Zonari E; Talotta F; Verde P; Blasi F
Oncogene; 2007 Feb; 26(5):725-32. PubMed ID: 16878153
[TBL] [Abstract][Full Text] [Related]
23. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter.
Hussain S; Kilbey A; Gillespie DA
Cell Growth Differ; 1998 Aug; 9(8):677-86. PubMed ID: 9716184
[TBL] [Abstract][Full Text] [Related]
24. Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription.
Thiel G; Al Sarraj J; Vinson C; Stefano L; Bach K
J Neurochem; 2005 Jan; 92(2):321-36. PubMed ID: 15663480
[TBL] [Abstract][Full Text] [Related]
25. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
[TBL] [Abstract][Full Text] [Related]
26. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
Leupold JH; Asangani I; Maurer GD; Lengyel E; Post S; Allgayer H
Mol Cancer Res; 2007 May; 5(5):485-96. PubMed ID: 17510314
[TBL] [Abstract][Full Text] [Related]
27. MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells.
Park JS; Park JH; Khoi PN; Joo YE; Jung YD
Carcinogenesis; 2011 Feb; 32(2):175-81. PubMed ID: 21081472
[TBL] [Abstract][Full Text] [Related]
28. A region between -141 and -61 bp containing a proximal AP-1 is essential for constitutive expression of urokinase-type plasminogen activator receptor.
Dang J; Boyd D; Wang H; Allgayer H; Doe WF; Wang Y
Eur J Biochem; 1999 Aug; 264(1):92-9. PubMed ID: 10447677
[TBL] [Abstract][Full Text] [Related]
29. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
Lengyel E; Gum R; Stepp E; Juarez J; Wang H; Boyd D
J Cell Biochem; 1996 Jun; 61(3):430-43. PubMed ID: 8761947
[TBL] [Abstract][Full Text] [Related]
30. Lysophosphatidic acid promotes cell invasion by up-regulating the urokinase-type plasminogen activator receptor in human gastric cancer cells.
Kim MH; Park JS; Chang HJ; Baek MK; Kim HR; Shin BA; Ahn BW; Jung YD
J Cell Biochem; 2008 Jun; 104(3):1102-12. PubMed ID: 18247343
[TBL] [Abstract][Full Text] [Related]
31. The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis.
Marinissen MJ; Chiariello M; Tanos T; Bernard O; Narumiya S; Gutkind JS
Mol Cell; 2004 Apr; 14(1):29-41. PubMed ID: 15068801
[TBL] [Abstract][Full Text] [Related]
32. Nrf1 in a complex with fosB, c-jun, junD and ATF2 forms the AP1 component at the TNF alpha promoter in stimulated mast cells.
Novotny V; Prieschl EE; Csonga R; Fabjani G; Baumruker T
Nucleic Acids Res; 1998 Dec; 26(23):5480-5. PubMed ID: 9826775
[TBL] [Abstract][Full Text] [Related]
33. Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress.
Hayakawa J; Mittal S; Wang Y; Korkmaz KS; Adamson E; English C; Ohmichi M; McClelland M; Mercola D
Mol Cell; 2004 Nov; 16(4):521-35. PubMed ID: 15546613
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor.
Wang Y; Dang J; Wang H; Allgayer H; Murrell GA; Boyd D
Eur J Biochem; 2000 Jun; 267(11):3248-54. PubMed ID: 10824110
[TBL] [Abstract][Full Text] [Related]
35. Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts.
Lu Z; Hornia A; Joseph T; Sukezane T; Frankel P; Zhong M; Bychenok S; Xu L; Feig LA; Foster DA
Mol Cell Biol; 2000 Jan; 20(2):462-7. PubMed ID: 10611224
[TBL] [Abstract][Full Text] [Related]
36. JAK/STAT3-dependent activation of the RalGDS/Ral pathway in M1 mouse myeloid leukemia cells.
Senga T; Iwamoto T; Kitamura T; Miyake Y; Hamaguchi M
J Biol Chem; 2001 Aug; 276(35):32678-81. PubMed ID: 11432872
[TBL] [Abstract][Full Text] [Related]
37. The murine urokinase-type plasminogen activator receptor gene.
Suh TT; Nerlov C; Danø K; Degen JL
J Biol Chem; 1994 Oct; 269(42):25992-8. PubMed ID: 7929309
[TBL] [Abstract][Full Text] [Related]
38. Aberrant polycystin-1 expression results in modification of activator protein-1 activity, whereas Wnt signaling remains unaffected.
Le NH; van der Bent P; Huls G; van de Wetering M; Loghman-Adham M; Ong AC; Calvet JP; Clevers H; Breuning MH; van Dam H; Peters DJ
J Biol Chem; 2004 Jun; 279(26):27472-81. PubMed ID: 15087466
[TBL] [Abstract][Full Text] [Related]
39. The JNK/AP1/ATF2 pathway is involved in H2O2-induced acetylcholinesterase expression during apoptosis.
Zhang JY; Jiang H; Gao W; Wu J; Peng K; Shi YF; Zhang XJ
Cell Mol Life Sci; 2008 May; 65(9):1435-45. PubMed ID: 18385943
[TBL] [Abstract][Full Text] [Related]
40. Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer.
Choi CY; Choi BH; Park GT; Rho HM
J Biol Chem; 1997 Jul; 272(27):16934-9. PubMed ID: 9202004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
